[Skip to Content]
[Skip to Content Landing]
Citations 0
January 9, 2002

Cost-effectiveness of Homocysteine-Lowering Therapy to Prevent Coronary Heart Disease

Author Affiliations

Stephen J.LurieMD, PhD, Senior Editor


Not Available

JAMA. 2002;287(2):191. doi:10.1001/jama.287.2.191-JLT0109-3-3

To the Editor: Dr Tice and colleagues1 concluded that grain fortification with folic acid and cyanocobalmin would be cost-effective, and even cost-saving, in reducing the risk of primary and secondary heart disease in the US population. However, 2 statements by the authors raise serious issues regarding the appropriate policy application of their findings.